Author

Tatiana Scandiuzzi Piovesan

Observed name: Tatiana Scanduzzi Piovesan

Institutions: AULSS 2 Marca Trevigiana, Ospedale San Giacomo Apostolo

Observed institutions: University of Trieste, AULSS 2 Marca Trevigiana, Ospedale San Giacomo Apostolo

ORCID: 0009-0009-7080-0859

Observed ORCID: 0009-0009-7080-0859

OpenAlex ID: A5092958378

iPSCs as a groundbreaking tool for the study of adverse drug reactions: A new avenue for personalized therapy

2023 · Paola Rispoli, Tatiana Scandiuzzi Piovesan, et al. · WIREs Mechanisms of Disease · 13

Tezepelumab Improves Small Airways Dysfunction in Severe Asthma: A 52‐Week Real‐World Study

2026 · Francesco Menzella, Marcello Cottini, et al. · Clinical and Translational Allergy · 8

Real-world effectiveness of tezepelumab on clinical remission and small airway dysfunction in severe asthma: a 52-week prospective study

2026 · Francesco Menzella, Rory Chan, et al. · Expert Opinion on Biological Therapy · 2

Dual Remission in Patients with Moderate-to-Severe Asthma and CRSwNP Treated with Dupilumab: A 24-Month Real-World Study

2026 · Francesco Menzella, Alvise Berti, et al. · Journal of Clinical Medicine · 2

Dual REmission in moderate-to-severe AsthMa and Nasal Polyps: a multicentric observational Phase IV real-life study (DREAM-NP)

2026 · Francesco Menzella, Eugenio De Corso, et al. · Expert Opinion on Biological Therapy

Dual REmission in moderate-to-severe AsthMa and Nasal Polyps: a multicentric observational Phase IV real-life study (DREAM-NP)

2026 · Francesco Menzella, Eugenio De Corso, et al. · Figshare

Mesoglycan for long-term secondary prevention in patients with superficial vein thrombosis (METRO): a multicentre randomised clinical trial in Italy

2026 · Giuseppe Camporese, Enrico Bernardi, et al. · EClinicalMedicine

Full- versus Reduced-Dose Direct Oral Anticoagulants for Extended Treatment of Cancer-Associated Thrombosis: A Multicenter Retrospective Cohort Study

2026 · Paolo Santini, Davide Santagata, et al. · Seminars in Thrombosis and Hemostasis

Real-world effectiveness of tezepelumab on clinical remission and small airway dysfunction in severe asthma: a 52-week prospective study

2026 · Francesco Menzella, Rory Chan, et al. · Figshare

Works count: 9

Citation count: 25

H-index: 2

I10-index: 1